Extracellular matrix components in breast cancer progression and metastasis.
暂无分享,去创建一个
[1] S. Ghatak,et al. Regulation of MDR1 Expression and Drug Resistance by a Positive Feedback Loop Involving Hyaluronan, Phosphoinositide 3-Kinase, and ErbB2*♦ , 2005, Journal of Biological Chemistry.
[2] Lilly Y. W. Bourguignon,et al. Signaling Properties of Hyaluronan Receptors* , 2002, The Journal of Biological Chemistry.
[3] M J Bissell,et al. Involvement of extracellular matrix constituents in breast cancer. , 1995, Seminars in cancer biology.
[4] H. Moch,et al. Periostin expression and epithelial-mesenchymal transition in cancer: a review and an update , 2011, Virchows Archiv.
[5] Li Yang,et al. Down-regulation of osteopontin expression by RNA interference affects cell proliferation and chemotherapy sensitivity of breast cancer MDA-MB-231 cells. , 2011, Molecular medicine reports.
[6] J. Pringle,et al. Tumour-associated tenascin-C isoforms promote breast cancer cell invasion and growth by matrix metalloproteinase-dependent and independent mechanisms , 2009, Breast Cancer Research.
[7] Richard O. Hynes,et al. The Extracellular Matrix: Not Just Pretty Fibrils , 2009, Science.
[8] S. Rafii,et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche , 2005, Nature.
[9] I. Kii,et al. Interaction between Periostin and BMP-1 Promotes Proteolytic Activation of Lysyl Oxidase* , 2010, The Journal of Biological Chemistry.
[10] O. Vasiljeva,et al. Tumor cell-derived and macrophage-derived cathepsin B promotes progression and lung metastasis of mammary cancer. , 2006, Cancer research.
[11] K. Hansen,et al. Rat mammary extracellular matrix composition and response to ibuprofen treatment during postpartum involution by differential GeLC-MS/MS analysis. , 2012, Journal of proteome research.
[12] J. Muschler,et al. Cell-matrix interactions in mammary gland development and breast cancer. , 2010, Cold Spring Harbor perspectives in biology.
[13] M. C. Ling,et al. Osteopontin induces increased invasiveness and plasminogen activator expression of human mammary epithelial cells , 1999, Oncogene.
[14] T. Sørlie,et al. Extracellular matrix signature identifies breast cancer subgroups with different clinical outcome , 2008, The Journal of pathology.
[15] A. Oates,et al. The identification of metastasis-related gene products in a rodent mammary tumour model. , 1996, Biochemical Society transactions.
[16] M. Waltham,et al. Antisense-mediated suppression of hyaluronan synthase 2 inhibits the tumorigenesis and progression of breast cancer. , 2005, Cancer research.
[17] N. Brünner,et al. Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in 8377 breast cancer patients. , 2002, Journal of the National Cancer Institute.
[18] N. Ishiguro,et al. Inhibition of hyaluronan synthesis in breast cancer cells by 4‐methylumbelliferone suppresses tumorigenicity in vitro and metastatic lesions of bone in vivo , 2012, International journal of cancer.
[19] Mikala Egeblad,et al. Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling , 2009, Cell.
[20] N. Tan,et al. Matricellular Proteins: A Sticky Affair with Cancers , 2012, Journal of oncology.
[21] Elizabeth R. Smith,et al. Restoration of positioning control following Disabled-2 expression in ovarian and breast tumor cells , 2000, Oncogene.
[22] C. Streuli,et al. Extracellular matrix controls insulin signaling in mammary epithelial cells through the RhoA/Rok pathway , 2009, Journal of cellular physiology.
[23] Philip M. Carpenter,et al. Laminin 332 Expression in Breast Carcinoma , 2012, Applied immunohistochemistry & molecular morphology : AIMM.
[24] W. Gerald,et al. Endogenous human microRNAs that suppress breast cancer metastasis , 2008, Nature.
[25] J. Wang-Rodriguez,et al. Motility Induction in Breast Carcinoma by Mammary Epithelial Laminin 332 (Laminin 5) , 2009, Molecular Cancer Research.
[26] N. Hynes,et al. Ablation of β1 integrin in mammary epithelium reveals a key role for integrin in glandular morphogenesis and differentiation , 2005, The Journal of cell biology.
[27] L. Cai,et al. Knockdown of osteopontin chemosensitizes MDA-MB-231 cells to cyclophosphamide by enhancing apoptosis through activating p38 MAPK pathway. , 2011, Cancer biotherapy & radiopharmaceuticals.
[28] N. Cho,et al. Invasive breast cancer induces laminin-332 upregulation and integrin β4 neoexpression in myofibroblasts to confer an anoikis-resistant phenotype during tissue remodeling , 2012, Breast Cancer Research.
[29] D. Berger,et al. Thrombospondin-1 and transforming growth factor-beta l promote breast tumor cell invasion through up-regulation of the plasminogen/plasmin system. , 1997, Surgery.
[30] H. Tamaki,et al. Tenascin expression in cancer cells and stroma of human breast cancer and its prognostic significance. , 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.
[31] G. Tuszynski,et al. Plasma thrombospondin levels in patients with gynecologic malignancies , 1994, Cancer.
[32] Mina J Bissell,et al. Normal and tumor-derived myoepithelial cells differ in their ability to interact with luminal breast epithelial cells for polarity and basement membrane deposition. , 2010, Journal of cell science.
[33] P. Clézardin,et al. Human breast tumors override the antiangiogenic effect of stromal thrombospondin‐1 in vivo , 2005, International journal of cancer.
[34] R. Khokha,et al. Binding to EGF receptor of a laminin-5 EGF-like fragment liberated during MMP-dependent mammary gland involution , 2003, The Journal of cell biology.
[35] V. Bramwell,et al. Serial Plasma Osteopontin Levels Have Prognostic Value in Metastatic Breast Cancer , 2006, Clinical Cancer Research.
[36] J. Noti. Adherence to osteopontin via alphavbeta3 suppresses phorbol ester-mediated apoptosis in MCF-7 breast cancer cells that overexpress protein kinase C-alpha. , 2000, International journal of oncology.
[37] C. Watson,et al. Stat5 as a Target for Regulation by Extracellular Matrix (*) , 1995, The Journal of Biological Chemistry.
[38] H. Nevanlinna,et al. Tenascin-C expression in invasion border of early breast cancer — A predictor of local and distant recurrence , 1998 .
[39] A. Mannermaa,et al. Increased hyaluronan content and stromal cell CD44 associate with HER2 positivity and poor prognosis in human breast cancer , 2013, International journal of cancer.
[40] T. Sakakura,et al. Involvement of large tenascin-C splice variants in breast cancer progression. , 2003, The American journal of pathology.
[41] Jean-Michel,et al. SPARC/osteonectin induces matrix metalloproteinase 2 activation in human breast cancer cell lines. , 1998, Cancer research.
[42] H. Moon,et al. Overexpression of membrane-type matrix metalloproteinase-1 gene induces mammary gland abnormalities and adenocarcinoma in transgenic mice. , 2001, Cancer research.
[43] M. Kusakabe,et al. Tenascin in breast cancer development--is epithelial tenascin a marker for poor prognosis? , 1995, Cancer letters.
[44] Mina J. Bissell,et al. The Hyaluronan Receptors CD44 and Rhamm (CD168) Form Complexes with ERK1,2 That Sustain High Basal Motility in Breast Cancer Cells* , 2007, Journal of Biological Chemistry.
[45] Y. Taniyama,et al. Role of periostin in cancer progression and metastasis: inhibition of breast cancer progression and metastasis by anti-periostin antibody in a murine model. , 2011, International journal of molecular medicine.
[46] S. Ghatak,et al. Regulation of Multidrug Resistance in Cancer Cells by Hyaluronan* , 2003, Journal of Biological Chemistry.
[47] J. Graham,et al. Expression of osteonectin mRNA in human breast tumours is inversely correlated with oestrogen receptor content. , 1997, European journal of cancer.
[48] R. Chiquet‐Ehrismann,et al. Tenascin-C induced signaling in cancer. , 2006, Cancer letters.
[49] Edi Brogi,et al. Breast cancer cells produce tenascin C as a metastatic niche component to colonize the lungs , 2011, Nature Medicine.
[50] P. Schedin. Pregnancy-associated breast cancer and metastasis , 2006, Nature Reviews Cancer.
[51] Quynh-Thu Le,et al. Lysyl oxidase is essential for hypoxia-induced metastasis , 2006, Nature.
[52] Bonnie F. Sloane,et al. Cathepsin B inhibition limits bone metastasis in breast cancer. , 2012, Cancer research.
[53] A. El-Karef,et al. Co‐stimulation of human breast cancer cells with transforming growth factor‐β and tenascin‐C enhances matrix metalloproteinase‐9 expression and cancer cell invasion , 2004, International journal of experimental pathology.
[54] S. Ménard,et al. Regulation of breast cancer response to chemotherapy by fibulin-1. , 2007, Cancer research.
[55] M. Watabe,et al. Hyaluronan synthase HAS2 promotes tumor progression in bone by stimulating the interaction of breast cancer stem-like cells with macrophages and stromal cells. , 2012, Cancer research.
[56] M. Loda,et al. Elevated Serum Periostin Levels in Patients with Bone Metastases from Breast but not Lung Cancer , 2003, Breast Cancer Research and Treatment.
[57] E. Brogi,et al. Macrophages and cathepsin proteases blunt chemotherapeutic response in breast cancer. , 2011, Genes & development.
[58] C H Streuli,et al. Laminin mediates tissue-specific gene expression in mammary epithelia , 1995, The Journal of cell biology.
[59] H. Rodemann,et al. Fibronectin and laminin increase resistance to ionizing radiation and the cytotoxic drug Ukrain® in human tumour and normal cells in vitro , 2003, International journal of radiation biology.
[60] R. Weinberg,et al. Systemic Endocrine Instigation of Indolent Tumor Growth Requires Osteopontin , 2008, Cell.
[61] R. Samant,et al. Osteopontin: an effector and an effect of tumor metastasis. , 2010, Current molecular medicine.
[62] Robin L. Anderson,et al. Integrin‐dependent response to laminin‐511 regulates breast tumor cell invasion and metastasis , 2012, International journal of cancer.
[63] J. Rubin,et al. sFRP-1 binds via its netrin-related motif to the N-module of thrombospondin-1 and blocks thrombospondin-1 stimulation of MDA-MB-231 breast carcinoma cell adhesion and migration. , 2011, Archives of biochemistry and biophysics.
[64] Kevin W Eliceiri,et al. Postpartum mammary gland involution drives progression of ductal carcinoma in situ through collagen and COX-2 , 2011, Nature Medicine.
[65] V. Seshan,et al. A CXCL1 Paracrine Network Links Cancer Chemoresistance and Metastasis , 2012, Cell.
[66] M. Del Vecchio,et al. Osteoprotegerin and osteopontin serum values in postmenopausal advanced breast cancer patients treated with anastrozole. , 2004, Endocrine-related cancer.
[67] H. Rui,et al. Stromal CD10 and SPARC expression in ductal carcinoma in situ (DCIS) patients predicts disease recurrence , 2010, Cancer biology & therapy.
[68] T. Stein,et al. Microenvironment of the Involuting Mammary Gland Mediates Mammary Cancer Progression , 2007, Journal of Mammary Gland Biology and Neoplasia.
[69] R. Moll,et al. Stromal remodeling and SPARC (secreted protein acid rich in cysteine) expression in invasive ductal carcinomas of the breast , 2005, Virchows Archiv.
[70] M. Hemler,et al. Disruption of laminin-integrin-CD151-focal adhesion kinase axis sensitizes breast cancer cells to ErbB2 antagonists. , 2010, Cancer Research.
[71] A. Jensen,et al. The cathepsin K inhibitor odanacatib suppresses bone resorption in women with breast cancer and established bone metastases: results of a 4-week, double-blind, randomized, controlled trial. , 2010, Clinical breast cancer.
[72] D. Neri,et al. Antibody-Mediated Delivery of Interleukin-2 to the Stroma of Breast Cancer Strongly Enhances the Potency of Chemotherapy , 2008, Clinical Cancer Research.
[73] J. Pollard,et al. Microenvironmental regulation of metastasis , 2009, Nature Reviews Cancer.
[74] J. Erler,et al. Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche. , 2009, Cancer cell.
[75] J. Lawler,et al. The effect of thrombospondin-1 on breast cancer metastasis , 2009, Breast Cancer Research and Treatment.
[76] Kornelia Polyak,et al. Heterogeneity for Stem Cell–Related Markers According to Tumor Subtype and Histologic Stage in Breast Cancer , 2010, Clinical Cancer Research.
[77] Luke A. Gilbert,et al. DNA Damage-Mediated Induction of a Chemoresistant Niche , 2010, Cell.
[78] Hamid Morjani,et al. Extracellular Matrix Proteins Modulate Antimigratory and Apoptotic Effects of Doxorubicin , 2012, Chemotherapy research and practice.
[79] S. Sleijfer,et al. Association of an Extracellular Matrix Gene Cluster with Breast Cancer Prognosis and Endocrine Therapy Response , 2008, Clinical Cancer Research.
[80] S. Kumar,et al. Angiogenic characteristics of circulating and tumoural thrombospondin-1 in breast cancer. , 2007, International journal of oncology.
[81] T. Nishiyama,et al. Incorporation of Tenascin-C into the Extracellular Matrix by Periostin Underlies an Extracellular Meshwork Architecture* , 2009, The Journal of Biological Chemistry.
[82] J. Foidart,et al. MT1-MMP protects breast carcinoma cells against type I collagen-induced apoptosis , 2012, Oncogene.
[83] Meenakshi Singh,et al. Remodeling of the mammary microenvironment after lactation promotes breast tumor cell metastasis. , 2006, The American journal of pathology.
[84] P. Schedin,et al. Reproductive state of rat mammary gland stroma modulates human breast cancer cell migration and invasion. , 2000, Cancer research.
[85] L. Gutierrez,et al. Thrombospondin-1: Multiple Paths to Inflammation , 2011, Mediators of inflammation.
[86] P. Heldin,et al. Silencing of hyaluronan synthase 2 suppresses the malignant phenotype of invasive breast cancer cells , 2007, International journal of cancer.
[87] Matthew J. Paszek,et al. Balancing forces: architectural control of mechanotransduction , 2011, Nature Reviews Molecular Cell Biology.
[88] F. O'Malley,et al. Elevated plasma osteopontin in metastatic breast cancer associated with increased tumor burden and decreased survival. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.
[89] V. Borges,et al. Epithelial and Mesenchymal Cell Biology Alternatively Activated Macrophages and Collagen Remodeling Characterize the Postpartum Involuting Mammary Gland across Species , 2010 .
[90] L. Hennighausen,et al. Regulation of Mammary Differentiation by Extracellular Matrix Involves Protein-tyrosine Phosphatases* , 1998, The Journal of Biological Chemistry.
[91] Hanna Y. Irie,et al. Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment , 2009, Nature.
[92] David Cameron,et al. A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancer , 2009, Nature Medicine.
[93] Wolfhard Semmler,et al. Cilengitide inhibits progression of experimental breast cancer bone metastases as imaged noninvasively using VCT, MRI and DCE‐MRI in a longitudinal in vivo study , 2011, International journal of cancer.
[94] D. Pinkel,et al. The Stromal Proteinase MMP3/Stromelysin-1 Promotes Mammary Carcinogenesis , 1999, Cell.
[95] Y. Hsiao,et al. SPARC (Osteonectin) in Breast Tumors of Different Histologic Types and Its Role in the Outcome of Invasive Ductal Carcinoma , 2010, The breast journal.
[96] T. Oskarsson,et al. Extracellular matrix players in metastatic niches , 2012, The EMBO journal.
[97] F. O'Malley,et al. Osteopontin and p53 expression are associated with tumor progression in a case of synchronous, bilateral, invasive mammary carcinomas. , 1997, Archives of pathology & laboratory medicine.
[98] V. Castronovo,et al. A cathepsin K inhibitor reduces breast cancer induced osteolysis and skeletal tumor burden. , 2007, Cancer research.
[99] J. F. Harris,et al. Osteopontin expression in a group of lymph node negative breast cancer patients , 1998, International journal of cancer.
[100] Hong Peng,et al. Interactions between cancer stem cells and their niche govern metastatic colonization , 2011, Nature.
[101] D. Noh,et al. Comparative profiling of plasma proteome from breast cancer patients reveals thrombospondin-1 and BRWD3 as serological biomarkers , 2011, Experimental & Molecular Medicine.
[102] Andy J. Minn,et al. Genes that mediate breast cancer metastasis to lung , 2005, Nature.
[103] Bonnie F. Sloane,et al. Inhibition of cathepsin B activity attenuates extracellular matrix degradation and inflammatory breast cancer invasion , 2011, Breast Cancer Research.